In a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
Jesper Hoiland
Advertisement
Articles by Jesper Hoiland
Advertisement
Latest Updated Articles
Beyond the Blame Game: How Pharma is Learning to CollaborateJanuary 13th 2015
Advertisement
Advertisement
Trending on PharmExec
1
The Legacy of Rutledge: How States and Congress Can Still Regulate Pharmacy Benefit Managers
2
Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset
3
FDA Approves Onswik for Adults with Type 2 Diabetes
4
FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC
5